Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Me Today (MEE) / FY23

Result released29 August 2023·Annolyse analysis published22 April 2026

Cash fell 83% to $0.9m despite PBT loss narrowing 41%

Losses narrowed materially, but a $5.6m operating cash burn left only $0.9m of cash against $12.4m of borrowings.

Consumer / Wellness products

MEE revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY23 was $3.6m, versus $2.4m in HY22.

MEE EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
HY23 was -85.4%, versus -75.6% in HY22.

MEE operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY23 was -$4.6m, versus -$4.6m in HY22.

MEE working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY22 MEE: Outside range high operating working-capital movement. $14.7m; 3-period range $-1.1m to $1.4m. Operating working-capital movement: NZ$14.7m, above normal range; 1/3 prior periods had builds averaging NZ$1.4m, and 2 had releases averaging NZ$-1.0m.
Operating working-capital movement: NZ$14.7m, above normal range; 1/3 prior periods had builds averaging NZ$1.4m, and 2 had releases averaging NZ$-1.0m.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 17 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$4.1m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not meaningful when recent earnings are negative.

EPS

-0.00

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not meaningful when recent EBITDA is negative.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

1.33x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
29 August 2023
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Revenue

$7.9m

Caveat: metric quality flags apply; use this value with basis context.

EBITDA

−$5.2m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

−$13m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

−$5.6m

Caveat: metric quality flags apply; use this value with basis context.

Operating profit

−$7.4m

Caveat: metric quality flags apply; use this value with basis context.

Profit before tax

−$13m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$0.91m

-83.0% ↓ vs $5.4m

Total assets

$27m

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofMEE FY23·Result released29 August 2023·Annolyse analysis published22 April 2026

What changed

Me Today narrowed its losses on slightly lower revenue, but cash drained to a level that dominates the read

Cash and equivalents fell 83.0% to NZ$0.9m (from NZ$5.4m), while gross borrowings edged up to NZ$12.4m and total equity halved to NZ$11.9m (-50.5%). Operating cash outflow improved to NZ$5.6m from NZ$11.6m, yet still consumed almost all of the prior cash balance.

On the P&L, revenue declined 4.7% to NZ$7.9m, EBITDA loss narrowed 8.9% to NZ$5.2m, PBT loss narrowed 41.4% to NZ$13.0m, and NPAT loss narrowed 33.6% to NZ$13.0m. Honey grew to NZ$5.8m and now contributes 63.2% of revenue (up from 57.0%); Me Today branded sales of NZ$2.8m shrank its share to 30.2%.

What matters

Liquidity is the central question

  • A NZ$0.9m cash balance against an annual operating outflow of NZ$5.6m and NZ$12.4m of gross borrowings (NZ$7.0m bank loans, NZ$5.4m subordinated note) implies the business cannot self-fund another year at the current burn. The narrowing of the loss is real, but it does not yet produce cash, which means external funding or further cost action is required to bridge to break-even.
  • PBT growth of 41.4% overstates the operating improvement against NPAT growth of 33.6%. The gap is driven by the prior year carrying a tax benefit (effective tax rate -11.8%) while the current period booked no tax (0.0%). PBT is the cleaner read of operating progress, so the underlying improvement is closer to the 41.4% line, but it still leaves a NZ$13.0m loss on NZ$7.9m of revenue.
  • Mix has tilted toward Honey while the branded business contracted. Honey revenue rose to NZ$5.8m with a smaller segment loss of NZ$1.2m (from NZ$1.9m), while Me Today branded sales of NZ$2.8m delivered a wider segment loss of NZ$2.4m. The strategy depends on the smaller, higher-burn branded business turning, not on Honey, so the mix shift is not unambiguously positive.

Expectations

No forward targets, forward-work backlog, or guidance metrics were supplied with this release, so this briefing cannot benchmark the result against a stated plan

The half-year shape shows H1 carried 59.7% of full-year EBITDA loss and 44.8% of full-year NPAT loss, implying an H2 EBITDA loss of NZ$2.1m (improving) but an H2 NPAT loss of NZ$7.2m (worsening). The widening H2 NPAT gap, in the absence of further explanation, points to below-EBITDA charges in the second half that the release does not itemise in the supplied excerpts. This matters because it leaves the trajectory into FY24 ambiguous: EBITDA momentum looks better, but reported NPAT got worse in the second half.

Quality of result

The reported improvement is genuine at the operating-loss level but light on cash-quality support

Operating cash conversion of 108.0% of EBITDA is within the company's historical range (3-period mean 98.9%), so the cash burn tracks the EBITDA loss rather than masking it; however, that simply confirms the business consumes cash in line with operating losses, not that it is approaching cash generation. Free cash flow before leases of -NZ$5.6m is within the company's historical baseline (mean -NZ$5.4m), which means the result is not a one-off improvement in capital intensity — capex was suppressed to NZ$0.04m (0.4% of revenue, down from 4.0%).

Working capital provided a modest tailwind: inventories fell NZ$2.0m (-12.1%) as honey stocks were worked down, partially offset by trade debtors rising 81.8% to NZ$1.7m, lifting debtor days to 76.9 (from 40.3). The receivable build is a watch-point because it converts reported revenue into balance-sheet exposure rather than cash, and it sits alongside inventory days of 683.5 that remain very high in absolute terms.

Unresolved

Open questions

What is the funding plan to bridge a NZ$0.9m cash balance against an ongoing NZ$5.6m annual operating outflow and NZ$12.4m of borrowings?
Why did H2 NPAT loss (NZ$7.2m) widen versus H1 (NZ$5.8m) when EBITDA improved, and what below-EBITDA charges drove that?
Is the strategic priority to scale the Me Today branded segment, which carries the largest segment loss (NZ$2.4m on NZ$2.8m of revenue), or to lean further into Honey, where economics are less loss-making?
How will trade debtors of NZ$1.7m (debtor days of 76.9) be collected, and is there customer concentration risk behind that build?
What covenants, maturities, or refinancing dates apply to the NZ$7.0m bank loan and NZ$5.4m subordinated note over the next 12 months?

This briefing cannot assess management's specific funding intentions, covenant headroom, or the post-balance-date liquidity position because no capital-raising plan, banking-facility detail, or going-concern commentary was supplied with the extraction.

Chat

Ask about MEE FY23

Ask follow-up questions about Me Today's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MEE FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Me Today's FY23 result.

What is the funding plan to bridge a NZ$0.9m cash balance against an ongoing NZ$5.6m annual operating outflow and NZ$12.4m of borrowings?Why does "Liquidity is the central question" matter?How strong was the cash and earnings quality in FY23?What should I watch next for MEE after FY23?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

30 June 2023 Financial Statements - Market Announcement

FY23 / results release↗

Me Today - Financial Statements 12 months ended 30 June 2023

FY23 / financial report↗

Rule 3.5 schedule at 29 August 2023

FY23 / results announcement↗

Prior comparable period

Me Today June 2022 Annual Report

FY22 / financial report↗

Interim context

31 December 2022 Financial Statements - Market Announcement

HY23 / results release↗

Me Today HY23 Interim Financial Statements 6 months ended 31 December 2022

HY23 / financial report↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 108.0% of EBITDA to operating cash flow, -96.8pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 7.8pp, with a distortion flag in the result.

→

ROE and capital efficiency

ROE was -108.7%, -27.6pp versus the prior comparable period.

→

Leverage and balance-sheet risk

Net debt / EBITDA is -2.20x, -1.00x versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MEE publishes next

Get the next Me Today briefing and related NZX reporting-season updates by email.